Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trial
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.21298
Authors: Björn Svensson, Annelies Boonen, Kristina Albertsson, Désirée van der Heijde, Catharina Keller, Ingiäld Hafström, for the BARFOT Study Group
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2084911737
